Preprint · OA
via OpenAlex
The Application of Conditional Reprogramming to Drug Discovery and Regenerative Medicine
DigitalGeorgetown (Georgetown University Library) · 2018
Abstract
Ph.D.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-06-30 MST
Cite this
APA
Alkhilaiwi, F. (2018). The Application of Conditional Reprogramming to Drug Discovery and Regenerative Medicine. <em>DigitalGeorgetown (Georgetown University Library)</em>. https://openalex.org/W2948333394
Vancouver
Alkhilaiwi F. The Application of Conditional Reprogramming to Drug Discovery and Regenerative Medicine. DigitalGeorgetown (Georgetown University Library). 2018.
BibTeX
@unpublished{faris2018TheApp,
title = {The Application of Conditional Reprogramming to Drug Discovery and Regenerative Medicine},
author = {Faris Alkhilaiwi},
journal = {DigitalGeorgetown (Georgetown University Library)},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Oxidative Medicine and Cellular Longevity 2021
Open access · CC-BY
Effects and Mechanisms of Resveratrol on Aging and Age‐Related Diseases
Nature Reviews Drug Discovery 2017
Open access · OA
Deubiquitylating enzymes and drug discovery: emerging opportunities
Nature Reviews Drug Discovery 2020
Preprint · OA
The quest to slow ageing through drug discovery
Acta Pharmacologica Sinica 2013
Open access · OA
Autophagy modulation as a target for anticancer drug discovery
Antioxidants 2024
Open access · CC-BY
Antioxidants and Mechanistic Insights for Managing Dry Age-Related Macular Degeneration
Cancer and Metastasis Reviews 2023
Open access · CC-BY